Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.

Employees

1,399

Sector

Pharmaceuticals

Calendar

09-04 Ex-dividend date - 4 INR

More about the company

Quotes

Date	Price	Change	Volume
27/08/26	₹236.99	-2.15%	66,137
26/08/26	₹242.20	+0.32%	76,102
25/08/26	₹241.43	+0.27%	44,621
24/08/26	₹240.77	+1.79%	219,001
21/08/26	₹236.54	+1.52%	92,791

Delayed Quote NSE India S.E.

More quotes

Market Closed - NSE India S.E. 15:05:08 27/08/2026 +04			5-day change	1st Jan Change
236.99 ^INR	-2.15%		+2.91%	+23.04%

07-30	Jagsonpal Pharmaceuticals Limited announces Annual dividend, payable on October 18, 2026	CI
07-29	Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Market Cap	12.32B 129M 111M 104M 95.06M 179M 180M 1.23B 477M 6.22B 485M 475M 20.59B	P/E 2024	32.7x	P/E 2025	26.4x
Enterprise Value	11.13B 117M 100M 93.99M 85.85M 162M 163M 1.11B 431M 5.61B 438M 429M 18.59B	EV / Sales 2024	2.84x	EV / Sales 2025	4.92x
Free-Float	23.94%	Yield 2024	1.81%	Yield 2025	1.15%

07-30	Jagsonpal Pharmaceuticals Limited announces Annual dividend, payable on October 18, 2026	CI
07-29	Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
07-17	Jagsonpal Pharmaceuticals Limited completed the acquisition of 85% stake in Aequitas Healthcare Private Limited.	CI
06-29	Jagsonpal Pharmaceuticals Limited entered into a definitive agreement to acquire 85% stake in Aequitas Healthcare Private Limited for approximately INR 210 million.	CI
05-25	Tranche Update on Jagsonpal Pharmaceuticals Limited's Equity Buyback Plan announced on March 12, 2026.	CI
05-18	Jagsonpal Pharmaceuticals Limited Announces Resignation of Pallavi Dinodia Gupta as the Independent Director, Effective May 18, 2026	CI
05-14	Jagsonpal Pharmaceuticals Limited's Equity Buyback announced on March 12, 2026, has closed with 1,600,000 shares, representing 2.44% for INR 400 million.	CI
05-07	Jagsonpal Pharmaceuticals Sets Dates for INR400 Million Buyback	MT
04-28	Jagsonpal Pharmaceuticals Net Profit Jumps in Fiscal Q4	MT
04-27	Jagsonpal Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended March 31, 2026	CI
04-27	Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-27	Jagsonpal Pharmaceuticals passes buy-back resolution	RE
03-13	Jagsonpal Pharmaceuticals gets order for tax demand of 48.2 million rupees	RE

30/08/22	Jagsonpal Pharmaceuticals : ESOP/ESPS/SBEB Scheme	PU
16/08/22	Jagsonpal Pharmaceuticals : Reply to Clarification Sought	PU
16/07/22	Jagsonpal Pharmaceuticals : Appointment	PU

Jagsonpal Pharmaceuticals Limited Stock

Stocks

JAGSNPHARM

INE048B01035

Pharmaceuticals

Valuation : Jagsonpal Pharmaceuticals Limited

Chart: Jagsonpal Pharmaceuticals Limited

Latest news : Jagsonpal Pharmaceuticals Limited

Press Releases : Jagsonpal Pharmaceuticals Limited

Quotes and Performance

Price Extremes

Managers and Directors : Jagsonpal Pharmaceuticals Limited

Other Pharmaceuticals

Financials

Company Profile

Quotes

1 day	-2.15%
1 week	+2.91%
Current month	+2.68%
1 month	+3.21%
3 months	+14.00%
6 months	+40.52%
Current year	+23.04%

1 week	229.54	248
1 month	217.18	263.7
Current year	155	264.5
1 year	155	264.5
3 years	109.44	328.04
5 years	49.2	328.04
10 years	6.5	328.04

Manager	Title	Age	Since
Manish Gupta CEO	Chief Executive Officer	59	16/07/2022
Nirav Niranjankumar Vora DFI	Director of Finance/CFO	-	07/10/2025
Amrut Medhekar COO	Chief Operating Officer	-	04/09/2025

Director	Title	Age	Since
Rajpal Singh Kochhar CHM	Chairman	69	04/12/2013
Harsha Raghavan CHM	Chairman	54	16/07/2022
Prithipal Singh Kochhar BRD	Director/Board Member	-	29/06/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JAGSONPAL PHARMACEUTICALS LIMITED	-2.15%	+2.91%	+1.34%	+41.94%	167M
ELI LILLY AND COMPANY	-1.07%	-7.10%	+61.60%	+114.83%	1,060B
JOHNSON & JOHNSON	-2.01%	-1.25%	+52.98%	+62.41%	651B
ABBVIE INC.	-1.64%	-1.15%	+26.18%	+79.22%	465B
ROCHE HOLDING AG	-1.56%	-2.12%	+38.58%	+40.42%	365B
NOVARTIS AG	-2.00%	-0.87%	+22.81%	+38.45%	300B
ASTRAZENECA PLC	-0.96%	+0.85%	+2.36%	+12.48%	258B
AMGEN INC.	-1.04%	-0.46%	+52.06%	+71.75%	238B
NOVO NORDISK A/S	-3.28%	-0.39%	-17.30%	-54.37%	210B
GILEAD SCIENCES, INC.	-0.90%	+0.33%	+29.05%	+92.67%	184B
Average	-1.54%	-0.08%	+26.97%	+49.98%	373.06B
Weighted average by Cap.	-1.30%	-2.15%	+39.56%	+67.37%

	2024	2025
Net sales	2.09B 21.88M 18.78M 17.63M 16.1M 30.38M 30.53M 209M 80.85M 1.05B 82.16M 80.38M 3.49B	2.69B 28.17M 24.18M 22.7M 20.73M 39.12M 39.31M 269M 104M 1.36B 106M 103M 4.49B
Net income	225M 2.36M 2.02M 1.9M 1.73M 3.27M 3.29M 22.45M 8.7M 113M 8.84M 8.65M 375M	554M 5.8M 4.98M 4.68M 4.27M 8.06M 8.1M 55.34M 21.45M 279M 21.79M 21.32M 925M
Net Debt	-1.39B -14.57M -12.51M -11.74M -10.72M -20.24M -20.33M -139M -53.84M -701M -54.72M -53.53M -2.32B	-1.19B -12.53M -10.75M -10.09M -9.22M -17.4M -17.48M -119M -46.29M -603M -47.04M -46.02M -2B